Skip to search.
 TSX Up1.03% TSX Ventures 0.00%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.05 May 21, 4:00PM EDT

Add to Portfolio
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2013-03-302012-12-302012-09-292012-06-29
Assets
Current Assets
Cash And Cash Equivalents87,343  14,677  20,248  21,100  
Short Term Investments -   -   -  6,012  
Net Receivables -   -   -  38  
Inventory -   -   -   -  
Other Current Assets1,744  430  558  190  
Total Current Assets 89,087   15,107   20,806   27,340  
Long Term Investments -   -   -   -  
Property Plant and Equipment91  56  59  51  
Goodwill3,208  3,208  3,208  3,208  
Intangible Assets -   -   -   -  
Accumulated Amortization -   -   -   -  
Other Assets163  198  198  209  
Deferred Long Term Asset Charges -   -   -   -  
Total Assets 92,549   18,569   24,271   30,808  
Liabilities
Current Liabilities
Accounts Payable8,656  8,039  7,687  9,283  
Short/Current Long Term Debt -   -   -   -  
Other Current Liabilities -   -   -   -  
Total Current Liabilities 8,656   8,039   7,687   9,283  
Long Term Debt -   -   -   -  
Other Liabilities24  36   -  11  
Deferred Long Term Liability Charges -   -   -   -  
Minority Interest -   -   -   -  
Negative Goodwill -   -   -   -  
Total Liabilities 8,680   8,075   7,687   9,294  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -   -  
Redeemable Preferred Stock -   -   -   -  
Preferred Stock -   -   -   -  
Common Stock82  72  72  72  
Retained Earnings(394,663)(392,608)(385,980)(380,505)
Treasury Stock(357)(357)(357)(357)
Capital Surplus478,807  403,387  402,849  402,304  
Other Stockholder Equity -   -   -   -  
Total Stockholder Equity 83,869   10,494   16,584   21,514  
Net Tangible Assets 80,661   7,286   13,376   18,306  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.